Asthma

Postgraduate Medical Journal

Volumn 72, Issue 843, 1996, Pages 12-18

  Calverley, Peter M A ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Asthma; British Thoracic Society guidelines; Compliance; Inflammation

Indexed keywords

AMINOPHYLLINE; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ASTHMA; BONE DISEASE; CONVULSION; CUSHING SYNDROME; DIAGNOSTIC ERROR; GASTROESOPHAGEAL REFLUX; GLAUCOMA; HEADACHE; HEART ARRHYTHMIA; HOARSENESS; HUMAN; HYPOKALEMIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MORBIDITY; MORTALITY; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; RELAPSE; REVIEW; SKIN DISEASE; TACHYCARDIA; TASTE DISORDER; TREMOR; VOMITING; XEROSTOMIA;

EID: 0030063941     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.72.843.12     Document Type: Review

References (29)

1. Sears M. Epidemiological trends in bronchial asthma. In: Kaliner MA, Barnes PJ, Persson CGA, eds. Asthma. Its pathology and treatment. New York: Marcel-Dekker, 1991; pp 1-49.
2. Burney P. Asthma death in England and Wales in 1931-85: evidence for a true increase in asthma mortality. J Epidemiol Commun Health 1988; 42: 316-20.
3. Bai TR. Abnormalities in airway smooth muscle in fatal asthma. Am Rev Respir Dis 1990; 141: 552-7.
4. Beasley R, Burgess C, Crane J, Pearce N, Roche WR. Pathology of asthma and its clinical implications. J Allergy Clin Immunol 1993; 92: 148-54.
5. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. Am Rev Respir Dis 1989; 140: 1745-53.
6. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
7. Glynn AA, Michaels L. Bronchial biopsy in chronic bronchitis and asthma. Thorax 1960; 15: 142-53.
8. Roche WR, Beasley R, Williams JH, et al. Sub-epithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1: 520-4.
9. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142:1407-13.
10. Djukanovic R, Wilson JW, Britten KM, et al. Effect of inhaled corticosteroid on an airway inflammation in symptoms in asthma. Am Rev Respir Dis 1992; 145: 669-74.
11. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma: glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016-25.
12. Higgins BG, Britton JR, Chinn S, et al. Comparison of bronchial reactivity and peak expiratory flow rate variability measurements for epidemiologic studies. Am Rev Respir Dis 1992; 145: 588-93.
13. Nisar M, Spence DPS, West D, et al. A mask to modify inspired air temperature and humidity and its effect on exercise-induced asthma. Thorax 1992; 47: 446-50.
14. Dorward AJ, Colloff MJ, MacKay NS, McSharry C, Thomson NC. Effect of house dust mite avoidance measures on adult atopic asthma. Thorax 1988; 43: 98-102.
15. Beasley R, Cushley M, Holgate ST. A selfmanagement plan in the treatment of adult asthma. Thorax 1989; 44: 200-4.
16. Rand CS, Wise RA, Nides M, et al. Metered dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559-64.
17. Yeung M, O'Connor SA, Parry DT, Cochrane GM. Compliance with prescribed drug therapy in asthma. Respir Med 1994; 88: 31-5.
18. Jack CIA, Calverley PMA, Donnelly RJ, et al. Simultaneous tracheal and oesphageal pH in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50: 201-4.
19. Corrigan CJ, Haczku A, Gemon-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993; 147: 549-57.
20. Schwartzstein RS, Fanta CH. Orally administered nifedipine in chronic stable asthma. Am Rev Respir Dis 1986; 134: 262-5.
21. Maesen FPV, Smeets JJ, Costongs MAL, Wald FDM, Cornelissen PJG. Ba679, a new long-acting anti-muscarinic bronchodilator: a pilot dose escalation study in COPD. Eur Respir J 1993; 6: 1031-6.
22. Williams AJ, Lee TH, Cochrane GM, et al. A potassium channel activator (cromakalim) attenuates nocturnal asthma. Lancet 1990; 336: 334-6.
23. Kidney JC, Worsdell YM, Lavender EA, Chung KF, Barnes PJ. The effect of an ATP dependent potassium channel activator, BRL 38227, in asthmatics. Am Rev Respir Dis 1991; 143: A423.
24. Brunnee T, Englestatter R, Steinijans VW, Kunkel G. Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor in patients with asthma. Eur Respir J 1992; 5: 982-5.
25. Gaddy JN, Margolskee DJ, Bush RK, Williams VC, Busse WW. Bronchodilatation with a potent and selective leukotriene D4 (LTD 4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis 1992; 146: 358-63.
26. Hui KP, Barnes NC. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet 1991; 337: 1062-3.
27. Israel E, Ruben P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Intern Med 1993; 119: 1059-66.
28. Chung KF. Platelet activating factor in inflammation and pulmonary disorders. Clin Sci 1992; 83: 127-38.
29. Spence DPS, Johnston SL, Calverley PMA, et al. The effect of the orally-active platelet activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994; 149: 1142-8.